Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea · Delayed Price · Currency is KRW 1,146.00
+6.00 (0.53%)
Oct 10, 2025, 3:30 PM KST
Enzychem Lifesciences Market Cap
Enzychem Lifesciences has a market cap or net worth of 88.97 billion as of October 10, 2025. Its market cap has decreased by -25.61% in one year.
Market Cap
88.97B
Enterprise Value
-17.98B
Revenue
72.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,146.00
Market Cap Chart
Since April 5, 2017, Enzychem Lifesciences's market cap has decreased from 217.47B to 88.97B, a decrease of -59.09%. That is a compound annual growth rate of -9.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 88.97B | -21.80% |
| Dec 30, 2024 | 113.77B | -26.43% |
| Dec 28, 2023 | 154.65B | 10.86% |
| Dec 29, 2022 | 139.50B | -69.50% |
| Dec 30, 2021 | 457.39B | -47.38% |
| Dec 30, 2020 | 869.25B | 57.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |